Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
SMaRT Replacement Therapy Evan Lum What is this? • SMaRT Replacement Therapy is a one-time topical treatment with the potential to treat tooth decay for life. • Developed by a Florida-based company called Oragenics What Causes Tooth Decay? • A bacterium called Streptococcus mutans (S. mutans) sits on the surface of the teeth. • This bacteria converts sugar in our mouth into lactic acid which erodes enamel and causes tooth decay. • Tooth decay is the process that results in cavities. • If untreated, this can cause pain, infection, and tooth loss. How Can SMaRT Prevent Tooth Decay? • Oragenics has developed a genetically altered strain of S. mutans, called SMaRT which does not produce lactic acid. • The strain is engineered with a colonization advantage over native S. mutans which are killed off, leaving the SMaRT strain unharmed. • So far testing has proved this to permanantly replace the old strain, resulting in permanent protection from tooth decay. Procedure • SMaRT Replacement Therapy is designed to be applied topically to the teeth by a dentist, pediatrician or primary care physician • The SMaRT strain is administered using a cotton-tipped swab during a single fiveminute, pain-free treatment. • The SMaRT strain will work to replace the old S. mutans over the next 6 to 12 months before full, permanent protection. Benefits • Tooth decay is mostly preventable by good oral hygiene. • However, it remains the most common chronic infectious disease in the world which means. • A one time, life long prevention of tooth decay would prevent this disease for those who don’t comply with an oral care regimen. Trials • The first Phase I clinical trial was initiated in 2005 but was stopped and postponed due FDA holds. • In Sept. 2007, the FDA removed the clinical hold and the Phase I trial continued. • As of now, only attenuated strains of SMaRT are being used, specific for D-Alanine, an amino acid not found in human diet. Results from Lab and Animal Models • No lactic acid creation under any cultivation conditions • Dramatically reduced ability to cause tooth decay • Aggressive displacement of native, decaycausing strains of S. mutans and preemptive colonization on the teeth of laboratory rats • No adverse side effects in either acute or chronic testing in rodent models Sources • http://www.webmd.com/oralhealth/tc/tooth-decay-topic-overview • http://www.oragenics.com/?q=cavityprevention • http://www.reuters.com/article/2009/03/19/i dUS206210+19-Mar-2009+BW20090319 • http://www.popularmechanics.com/science/h ealth/breakthroughs/4303407 THE END